NeuroBo to Present Latest Pre-Clinical Data on Cardiometabol

/PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company focused on the transformation of cardiometabolic diseases,...

Related Keywords

Milan , Lombardia , Italy , United States , Cambridge , Cambridgeshire , United Kingdom , American , Michael Feigh , Ahyoung Kim , Michael Miller , Yuna Chae , Su Jin Lee , Hoon Jung , Henrikb Hansen , Monika Lewinska , Sujin Lee , Shun Jung , Mi Kyung Kim , Marshallh Woodworth , Nasdaq , Neurobo Pharmaceuticals , American Diabetes Association , Donga St Co , Members Of The Donga St Research Center , Neurobo Pharmaceuticals Inc , Donga St Research Center , Prnewswire Neurobo Pharmaceuticals Inc , Scientific Research , Contract Research Organization , Scientific Sessions , Hyung Heon Kim , Chief Executive Officer , G Protein Coupled Receptor , Induced Liver , Tae Hyoung Kim , Additive Hepatoprotective Effects , Induced Obese , Biopsy Confirmed Mouse Model , Susanne Pors , Vice President Scientific Research , Promising Approach , Obesity Treatment , Il Hun Jung , Presentation Number , Metabolic Dysfunction Associated Steatohepatitis , Private Securities Litigation Reform Act ,